日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel.

抑制线粒体相关蛋白 MAGMAS 可使耐药性前列腺癌细胞重新对多西他赛敏感

Durán Alfonso M, Whitley Kristen, Santiago Krystal, Yoo Christian, Valdez Giancarlo, Cheng Kai Wen, Ochoa Pedro, de Semir David, Xiu Joanne, Chokkalingam Parthiban, Das Sasmita, Schaefer Eric S, Rowe Steven P, Das Bhaskar C, Casiano Carlos A, Almaguel Frankis

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

在PD-L1未选择的转移性非小细胞肺癌患者中,斯帕塔利珠单抗联合铂类双药化疗,可联合或不联合卡那单抗。

Santoro, Armando; Pilar, Garrido; Tan, Daniel S W; Zugazagoitia, Jon; Shepherd, Frances A; Bearz, Alessandra; Barlesi, Fabrice; Kim, Tae Min; Overbeck, Tobias R; Felip, Enriqueta; Cai, Can; Eddy, Simantini; McCulloch, Tracey; Schaefer, Eric S

Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

更正:在PD-L1未选择的转移性非小细胞肺癌患者中,Spartalizumab联合铂类双药化疗(可联合或不联合canakinumab)治疗

Santoro, Armando; Pilar, Garrido; Tan, Daniel S W; Zugazagoitia, Jon; Shepherd, Frances A; Bearz, Alessandra; Barlesi, Fabrice; Kim, Tae Min; Overbeck, Tobias R; Felip, Enriqueta; Cai, Can; Eddy, Simantini; McCulloch, Tracey; Schaefer, Eric S

Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer

针对晚期ALK阳性非小细胞肺癌患者使用色瑞替尼可能出现的胃肠道不良反应,应采取积极的管理策略

Schaefer, Eric S; Baik, Christina